These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1001 related items for PubMed ID: 22440312

  • 1. 115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.
    Choudhury R, Das P, De T, Chakraborti T.
    Immunobiology; 2013 Jan; 218(1):114-26. PubMed ID: 22440312
    [Abstract] [Full Text] [Related]

  • 2. Leishmania donovani serine protease encapsulated in liposome elicits protective immunity in experimental visceral leishmaniasis.
    Das P, Paik D, Naskar K, Chakraborti T.
    Microbes Infect; 2018 Jan; 20(1):37-47. PubMed ID: 28970116
    [Abstract] [Full Text] [Related]

  • 3. Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge.
    Kushawaha PK, Gupta R, Sundar S, Sahasrabuddhe AA, Dube A.
    J Immunol; 2011 Dec 15; 187(12):6417-27. PubMed ID: 22079980
    [Abstract] [Full Text] [Related]

  • 4. TLR-mediated distinct IFN-γ/IL-10 pattern induces protective immunity against murine visceral leishmaniasis.
    Paul J, Karmakar S, De T.
    Eur J Immunol; 2012 Aug 15; 42(8):2087-99. PubMed ID: 22622993
    [Abstract] [Full Text] [Related]

  • 5. Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.
    Melby PC, Yang J, Zhao W, Perez LE, Cheng J.
    Infect Immun; 2001 Aug 15; 69(8):4719-25. PubMed ID: 11447143
    [Abstract] [Full Text] [Related]

  • 6. Induction of cellular and humoral responses by autoclaved and heat-killed antigen of Leishmania donovani in experimental visceral leishmaniasis.
    Nagill R, Mahajan R, Sharma M, Kaur S.
    Parasitol Int; 2009 Dec 15; 58(4):359-66. PubMed ID: 19638322
    [Abstract] [Full Text] [Related]

  • 7. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK, Naskar K, De T.
    Eur J Immunol; 2009 Aug 15; 39(8):2146-60. PubMed ID: 19593771
    [Abstract] [Full Text] [Related]

  • 8. Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-type immunoprotective response against experimental visceral leishmaniasis.
    Samant M, Gupta R, Kumari S, Misra P, Khare P, Kushawaha PK, Sahasrabuddhe AA, Dube A.
    J Immunol; 2009 Jul 01; 183(1):470-9. PubMed ID: 19542458
    [Abstract] [Full Text] [Related]

  • 9. Enhanced efficacy and immunogenicity of 78kDa antigen formulated in various adjuvants against murine visceral leishmaniasis.
    Nagill R, Kaur S.
    Vaccine; 2010 May 21; 28(23):4002-12. PubMed ID: 20093205
    [Abstract] [Full Text] [Related]

  • 10. Ubiquitin conjugation of open reading frame F DNA vaccine leads to enhanced cell-mediated immune response and induces protection against both antimony-susceptible and -resistant strains of Leishmania donovani.
    Sharma A, Madhubala R.
    J Immunol; 2009 Dec 15; 183(12):7719-31. PubMed ID: 19933862
    [Abstract] [Full Text] [Related]

  • 11. Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasis.
    Kumari S, Samant M, Misra P, Khare P, Sisodia B, Shasany AK, Dube A.
    Vaccine; 2008 Oct 23; 26(45):5700-11. PubMed ID: 18762224
    [Abstract] [Full Text] [Related]

  • 12. A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice.
    Mazumdar T, Anam K, Ali N.
    Vaccine; 2004 Mar 12; 22(9-10):1162-71. PubMed ID: 15003644
    [Abstract] [Full Text] [Related]

  • 13. Studies on the protective efficacy and immunogenicity of Hsp70 and Hsp83 based vaccine formulations in Leishmania donovani infected BALB/c mice.
    Kaur J, Kaur T, Kaur S.
    Acta Trop; 2011 Jul 12; 119(1):50-6. PubMed ID: 21530477
    [Abstract] [Full Text] [Related]

  • 14. Studies on the protective efficacy of freeze thawed promastigote antigen of Leishmania donovani along with various adjuvants against visceral leishmaniasis infection in mice.
    Thakur A, Kaur H, Kaur S.
    Immunobiology; 2015 Sep 12; 220(9):1031-8. PubMed ID: 26001730
    [Abstract] [Full Text] [Related]

  • 15. gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB/c mice infected with Leishmania donovani.
    Bhowmick S, Ravindran R, Ali N.
    Infect Immun; 2008 Mar 12; 76(3):1003-15. PubMed ID: 18195029
    [Abstract] [Full Text] [Related]

  • 16. Vaccination with liposomal leishmanial antigens adjuvanted with monophosphoryl lipid-trehalose dicorynomycolate (MPL-TDM) confers long-term protection against visceral leishmaniasis through a human administrable route.
    Ravindran R, Maji M, Ali N.
    Mol Pharm; 2012 Jan 01; 9(1):59-70. PubMed ID: 22133194
    [Abstract] [Full Text] [Related]

  • 17. Co-administration of IL-12 DNA with rORFF antigen confers long-term protective immunity against experimental visceral leishmaniaisis.
    Tewary P, Saxena S, Madhubala R.
    Vaccine; 2006 Mar 20; 24(13):2409-16. PubMed ID: 16413950
    [Abstract] [Full Text] [Related]

  • 18. Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum.
    Fiuza JA, Gannavaram S, Santiago Hda C, Selvapandiyan A, Souza DM, Passos LS, de Mendonça LZ, Lemos-Giunchetti Dda S, Ricci ND, Bartholomeu DC, Giunchetti RC, Bueno LL, Correa-Oliveira R, Nakhasi HL, Fujiwara RT.
    Vaccine; 2015 Jan 03; 33(2):280-8. PubMed ID: 25475955
    [Abstract] [Full Text] [Related]

  • 19. Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response.
    Bhowmick S, Ravindran R, Ali N.
    Vaccine; 2007 Aug 29; 25(35):6544-56. PubMed ID: 17655984
    [Abstract] [Full Text] [Related]

  • 20. Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis.
    Basu R, Bhaumik S, Basu JM, Naskar K, De T, Roy S.
    J Immunol; 2005 Jun 01; 174(11):7160-71. PubMed ID: 15905560
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.